Achieve Life Sciences (ACHV) Director Jeffrey Farrow Receives Equity Awards

What Happened Jeffrey S. Farrow, a director of Achieve Life Sciences, received equity awards on July 27, 2026: 25,000 derivative awards (options) and 16,700 restricted stock units (RSUs). Both grants are recorded at $0 (standard for awards) and do not reflect a cash purchase or sale.

Key Details

• Transaction date: 2026-07-27; Form 4 filed: 2026-07-29 (timely — within the 2-business-day window).
• Grants: 25,000 options (derivative award) and 16,700 RSUs; grant price shown as $0.
• Vesting: Options vest 100% on the earlier of July 27, 2027 or the date immediately prior to the issuer’s 2027 annual meeting, subject to continued service (Footnote F1). RSUs settle one-for-one into common shares and vest on the same schedule (Footnotes F2, F3).
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Transaction code: A = Award/Grant. This is compensation, not a market purchase or sale.

Context These are standard equity compensation awards to a director. RSUs convert to one common share each at settlement if vesting conditions are met; the options are not exercised here. Such grants are routine corporate compensation and do not by themselves indicate a director buying or selling stock in the open market.